The effect of hyperthermia on solid glioma tissue formed subcutaneously in the left femoral region of female F344 rats was investigated. Magnetite cationic liposomes (MCLs), which have a positive surface charge, were used as heating mediators for intracellular hyperthermia. MCLs were injected into the solid tumors, which were then subjected to irradiation by an alternating magnetic field (118 kHz, 384 Oe). The rats were divided into four groups, which received no irradiation (control: group I), or irradiation for 30 min given once (group II), twice (group III) or three times (group IV), and the hyperthermic effect on tumor growth was evaluated. Complete tumor regression was observed in 87.5% of the rats in group IV. In the other groups, tumors completely regressed in 20 and 60% of the rats in groups II and III, respectively. Histological observations showed that in group I tumors, MCLs were localized only around the point where they were injected, while in group II tumors they were a little more dispersed. In the cases of group III and IV tumors, however, the distribution of the MCLs was found to be widespread, and necrotic cells were observed throughout almost the entire tumor tissue. The high percentage of complete regression of group IV is considered to be due to this wide distribution of the MCLs. Furthermore, the treated rats showed no severe side-effects. These results suggest that our magnetic particles are potentially effective tools for the treatment of solid tumors.
Conventional therapies commonly employed in cancer treatment, including surgery, radiotherapy, and chemotherapy, are not very effective in the treatment of certain cancers such as glioblastoma, for which a novel and effective method of treatment is desired. Hyperthermia is seen as a promising therapy for such cancers. 1) Hyperthermia therapy is based on the fact that tumor cells are more sensitive to temperature than normal tissue cells. [2] [3] [4] However, the difficulty of achieving the necessary selective heating remains an important technical problem to be solved. 5, 6) Implantable needles have been developed for use as heating mediators in hyperthermia therapy. However, the procedure is very painful for the patient because many needles must be implanted to achieve homogeneous heating of tumor tissue. 7, 8) If fine particles can be used as heating mediators instead of needles, this difficulty may be overcome. For this reason, we developed submicronsized magnetite particles for heating tumor cells. 9) Because magnetite is ferromagnetic, heat is generated within the particles under an alternating magnetic field, 10) and they are easily incorporated into cells since their diameter is only 10-40 nm.
For administering magnetite particles to the body, we also developed particles coated with a liposomal membrane, 'magnetoliposomes' (MLs), and investigated both their magnetic properties and their application for hyperthermic simulation. 10, 11) Although the MLs are biocompatible and are highly dispersed in an aqueous solution, in vitro experiments using glioma cells as a tumor model revealed that their adsorption and accumulation into glioma cells was insufficient. Recently, we developed 'magnetite cationic liposomes' (MCLs) with improved adsorption and accumulation properties. 12) MCLs, which have a positive surface charge, show ten-fold higher affinity for glioma cells than neutrally charged MLs. This is caused by the electrostatic interaction with the negatively charged phospholipid cell membrane. 13, 14) The hyperthermic effect of MCLs was examined in vitro. 12) Glioma cells were incubated with MCL-containing medium and were collected as a cell pellet 80 µl in volume (5.4 mm in diameter), and then an alternating magnetic field (384 Oe, 118 kHz) was applied to the cell pellet. The temperature of the cell pellet increased to over 42°C, and the number of viable cells markedly decreased. After 40-min irradiation, no viable cells remained. 12) An ex vivo study was also conducted to examine the effect of intracellular heating of the tumor cells on tumor take.
15) The cell pellet incorporating MCLs was subcutaneously injected into the leg in F344 rats and the alternating magnetic field was applied. The growth of tumor tissue was found to be significantly suppressed by multiple magnetic field irradiations.
The above results were obtained under experimental conditions, in which almost all the tumor cells uniformly incorporated MCLs. Here, we report on an in vivo study, in which MCLs were injected into solid tumor tissue formed subcutaneously in F344 rats and subjected to magnetic field irradiation. The effectiveness of the treatment in suppressing tumor growth was evaluated.
MATERIALS AND METHODS

Materials
Dilauroylphosphatidylcholine (DLPC) and dioleoylphosphatidylethanolamine (DOPE) were purchased from Sigma Chemical Co. (St. Louis, MO), and N-(α-trimethylammonioacetyl)didodecyl-D-glutamate chloride (TMAG) was from Sogo Pharmaceutical Co., Ltd. (Tokyo). All other chemicals were obtained from Wako Pure Chemical Industries Co., Ltd. (Osaka). Cell culture The rat glioma cell line T-9 was used. The cells were maintained at 37°C in a 5% CO 2 atmosphere in Eagle's minimum essential medium (Gibco BRL, Gaithersburg, MD) supplemented with 10% fetal bovine serum, 5 mM nonessential amino acids, and antibiotics (100 U/ml penicillin and 100 µg/ml streptomycin). Preparation of the MCLs Magnetite (Fe 3 O 4 ; average particle size: 10 nm), used as the core of the MCLs, was kindly provided by Toda Kogyo Co., Ltd. (Hiroshima). MCLs were prepared by the sonication method as described previously with some modification. 12, 15) Briefly, a magnetite slurry was washed with distilled water to remove remaining ions. The washing step was repeated until a stable dispersion of magnetite particles was obtained. In a round-bottomed flask, 2 ml of the colloidal magnetite (net weight: 20 mg) was added to a lipid film which consisted of a mixture of TMAG, DLPC, and DOPE in the molar ratio of 1:2:2 (total lipid amount: 15 mg). The flask was immediately shaken vigorously by vortex mixing, and the mixture of lipid and magnetite colloid was sonicated for 15 min in a bath-type sonicator (BS-100 Sunpar; Iuchi Co., Ltd., Tokyo). The pH of the sonicated mixture was adjusted to 7.4 by adding 200 µl of 1.5 M NaCl and 0.5 M Na phosphate buffer, and the solution was sonicated again for 15 min. All MCL concentration values are expressed as the net magnetite concentration. Preparation of tumor-bearing rats To prepare tumorbearing animals, rat glioma T-9 cell suspensions (approximately 1×10 7 cells in 100 µl of phosphate buffer (0.05 M Na phosphate and 0.15 M NaCl, pH 7.4)) were injected subcutaneously into the left femoral region of female F344 rats (6-7 weeks old) under short-term anesthesia by intraperitoneal injection of Nembutal. The rats were then separated into four groups. Animals in group I, the control group, were not subjected to magnetic field irradiation, while those in groups II, III, and IV were irradiated once, twice, or three times, respectively (see Table I ). Each group consisted of 10-13 rats. Five to eight animals in each group were used for monitoring tumor growth; the others were employed for the observation of histological features of various tissues. Tumor sizes were measured every 2 days. The volume was determined by use of the following formula 16) :
where the unit of length and width is the millimeter. In vivo hyperthermia On the 11th day after transplantation, when ellipsoidal tumors 13-18 mm in length had formed, the needle (needle size: 25 G) of a syringe containing MCL solution was inserted in the longitudinal direction subcutaneously from the tumor edge. Then 400 µl of MCL solution (net magnetite weight: 3 mg) was injected at the center of the tumor in each rat using an infusion pump (SP100i; World Precision Instruments Inc., Sarasota, FL, USA) for 30 min. Twenty-four hours after the injections, rats in groups II, III, and IV were anesthetized again and subjected to the first hyperthermia treatment. A magnetic field was created by using a horizontal coil (inner diameter: 7 cm; length: 7 cm) with a transistor inverter (LTG-100-05 (5.0 kW, 118 kHz); Dai-ichi High Frequency Co., Ltd., Tokyo). The magnetic field within the coil was theoretically almost homogeneous (384±20 Oe) within a range of 90% of the radius (3.2 cm from the center) and 43% of the coil length (3 cm from the cen- 17) Anesthetized rats were laid inside the coil such that the tumor region was at the center. The magnetic field frequency and intensity were 118 kHz and 30.6 kA/m (384 Oe), respectively. Treatment was carried out for 30 min and repeated at 24-h intervals for groups III and IV. Tumor and rectum temperatures were measured by means of an optical fiber probe (FX-9020; Anritsu Meter Co., Ltd., Tokyo).
Preparation of specimens for histological observation
On the 4th day after the MCL injection, the animals were killed, and the tumors and various organs were removed and prepared as follows. After the replacement of blood with phosphate buffer, the tumor, heart, lungs, liver, spleen, and kidneys were extracted, fixed with 10% formalin solution, and sectioned longitudinally. Pathological specimens 6 µm in thickness were prepared, stained with Berlin blue to visualize the location of the MCLs and counterstained with Kernechtrot, or stained with hematoxylin and eosin.
Animal experiments were performed according to the principles laid down in the "Guide for the Care and Use of Laboratory Animals" prepared under the direction of the Office of the Prime Minister of Japan.
RESULTS
Heat generation by MCLs in an alternating magnetic field
We measured the temperature inside the tumor in the region containing the injected MCLs, as well as inside and outside the skin covering the tumor, and in the rectum. The temperatures inside and outside the skin were closely similar, but that inside the tumor was higher (data not shown). The hyperthermic effect at the peripheral area of the tumor would be lower than that inside the tumor. The whole of the tumor needs to be heated over 43°C. The temperature at the outside of the skin covering the tumor was thus monitored with an optical fiber thermometer closely affixed to the skin above the tumor with adhesive tape. In the case of the rectum, the optical fiber was directly inserted into the rectum. Fig. 1 shows the temperature increases on the outside of the skin covering the tumor and in the rectum. The temperature of the tumor was elevated rapidly by magnetic heating and reached over 43°C after 15 min. In contrast, the temperature in the rectum remained between 35 and 37°C. When magnetic field irradiation was extended beyond 30 min, the temperature on the outside of the skin continued to increase gradually, and in some rats an obvious burn was observed on the skin covering the tumor. Therefore, the magnetic field was applied for 30 min in the following experiment. Fig. 2 shows the time courses of tumor growth of 5 rats in each group. In group I animals, the tumor volume in each rat steadily increased with no evidence of regression. In contrast, complete tumor regression was observed in many of the rats irradiated with the magnetic field. Fig. 3 shows photographs of typical rats from groups I and IV on the 28th day after the MCL injection. In most cases of complete regression, the tumor volume increased up to the 12th day, after which it began to decrease and finally the tumor disappeared. No regrowth of tumors was observed following complete regression over a period of 3 months (data not shown in Fig. 2) . Table I shows the average tumor volumes and ratios of complete regression on the 30th day after the MCL injec- tion. In group II, the decrease in the average tumor volume was not significant. However, in the cases of groups III and IV, in which the animals received repeated treatment, the average tumor volume decreased markedly. Complete regression was observed in one of the five rats in group II, three of the five in group III, and seven of the eight in group IV, confirming the effectiveness of multiple irradiation in attaining tumor regression. In group IV, only one tumor did not regress. Since the shape of this tumor was not ellipsoidal but irregular, it is likely that the MCLs could not heat the whole of the tumor homogeneously even when it was irradiated three times. To achieve complete regression in such a case, multiple injection of MCLs may be necessary. Histological features of tumors after hyperthermia treatment Fig. 4 shows non-stained tumor sections (A) and sections stained with hematoxylin-eosin (B). In Fig.  4 , A I to A IV , MCLs are evident as regions dark-brown in color. In the group I specimen (Fig. 4A I ) , the MCLs are very localized around the point where the needle was inserted. In contrast, the MCLs in the group II, III, and IV specimens are more widely distributed.
Monitoring tumor growth after hyperthermia
The MCL areas in groups II, III, and IV coincide well with the necrotic areas observed in Fig. 4, B II , B III , and B IV . In the group II specimen, the necrotic area is small and similar to the MCL area in Fig. 4A II . In the group III and IV specimens, although the necrotic area spread with repeated treatment, it is never wider than the corresponding MCL area. Therefore, the hyperthermic effect was greatly improved in the group III and IV rats, even though the initial distribution of the MCLs was very localized. This feature is never found in hyperthermia treatment using implantable needles. Distribution of MCL and hyperthermic effect in various organs Fig. 5 shows microscopic sections of a tumor and organs removed from one of the group IV rats. There is no evidence of MCLs in the liver, lung, and heart tissue. However, MCLs can be observed in the kidney and especially in the spleen. Similar results were obtained with all the groups regardless of the hyperthermia treatment, presumably due to a characteristic of the liposomes which facilitates their accumulation in these particular organs. However, even in the group IV rats irradiated three times, no necrotic cells were detected in the spleen or kidney. The temperature of the spleen or kidneys seems not to have increased since the concentrations of MCLs in these organs were low and the MCLs were located sporadically, so the generated heat seems to have been removed by the blood flow. Furthermore, weight gain of rats was also monitored for 90 days. The gains of rats in which glioma tissue regressed completely were similar to those of the control rats without glioma tissue (data not shown), and side-effects such as unusual behavior or hematuria were not observed.
DISCUSSION
From preliminary experiments, 80-90% of the injected MCLs was accumulated in the tumor tissue, whereas only 20-25% of the neutral magnetoliposomes was accumulated. This high accumulation of MCLs is considered to be due to the cationic charge on the surface of the liposomes, and consequently a high hyperthermic effect was obtained, as shown in Figs. 2 and 3 .
As shown in Fig. 4A , the MCLs in the group II, III, and IV specimens are quite widely distributed, although they are very localized around the point where the needle was inserted in the group I specimen. In order to explain the wide distribution of the MCLs, two hypotheses can be considered. One is a direct force due to the alternating magnetic field and the other is a change in the tumor tissues caused by hyperthermia treatment. In the present experiments, the magnetic field within the coil was parallel to the central axis of the coil. A direct force on the magnetite particles may be generated parallel to the central axis of the coil, and the MCL area should therefore expand only in this direction. However, the MCL area in fact expanded in all directions, as shown in Fig. 4A , so the first hypothesis must be discarded.
The temperatures on the outside of the skin covering the tumor increased to about 44°C. However, it would have been higher inside the tumor, especially in the regions containing MCLs. The cells at these areas would become necrotic and the structure would become looser. The MCL area coincided well with the necrotic area, as shown in Fig. 4B . This suggests that the MCLs diffuse throughout the necrotic tissue and the MCL area became wider with repeated irradiation. Therefore, it appears that the latter hypothesis can explain the wide distribution of the MCL.
In the one case from group IV in which no regression occurred, the tumor was irregular in shape and consisted of two masses. The initial distribution of the MCLs would thus have been inappropriate, and as a result the MCLs would not have been widely distributed by the multiple treatments. For a solid tumor of such irregular shape, the injection site and/or the direction of the injection should be considered carefully. Additional administrations of MCLs into plural sites would also be effective.
In the present study, full-power magnetic field irradiation was applied in order to heat the tumor as high as possible. In the case of a tumor in the brain, however, if the tumor is small or the MCLs are inaccurately injected at the tumor surface, a large temperature increase would cause severe damage to the surrounding normal brain tissue. Therefore, in such cases, the temperature should be controlled at around 43°C, which is a sufficient temperature to kill tumor cells within a 40-min heating period. 12) Such temperature control can be achieved by adjusting the magnetic field strength. To control the temperature increase more precisely, we proposed simulation of the temperature increase in the tumor using the information on MCLs distribution. 10) Computer simulation and temperature control would be important for safety during hyperthermia operations.
In summary, specially developed MCLs were used in the in vivo treatment of solid tumors by hyperthermia. The tumor tissue completely disappeared in many rats subjected to magnetic field irradiation, even though the treatment was carried out simply by administering the MCLs at one site. The ratio of complete regression increased with repeated irradiation. The MCLs thus seem to be novel and potentially effective heating mediators for the treatment of malignant solid tumors by hyperthermia without severe side-effects, although we have so far examined only one tumor cell line.
